Ledipasvir-Sofosbuvir +/- 3 rd DAA in HCV Genotype 1 SYNERGY
Ledipasvir-Sofosbuvir in GT-1 and HIV Coinfection ERADICATE Trial
Ledipasvir-sofosbuvir +/- 3 rd DAA in HCV Genotype 1 NIH SYNERGY